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Abstract  Dengue  is  one  of  the  most  serious  and  rapidly  emerging  tropical  mosquito-
borne  diseases.  The  state  of  Kerala  in  India  is  hyperendemic  for  the  disease  and  is
one  of  the  leading  states  in  the  reporting  of  deaths  due  to  dengue.  As  primary  pre-
vention  of  dengue  has  had  limited  success,  the  prevention  of  mortality  through
the  identiﬁcation  of  risk  factors  and  efﬁcient  patient  management  is  of  utmost
importance.  Hence,  a  record-based  case  control  study  was  conducted  in  the  Medical
College  Hospital  in  Thiruvananthapuram  to  identify  the  risk  factors  of  mortality  in
patients  admitted  with  dengue.  Dengue  patients  over  40  years  of  age  were  9.3  times
(95%  CI;  1.9—44.4)  more  likely  to  die  compared  with  younger  patients.  The  clini-
cal  features  associated  with  mortality  from  dengue  were  altered  sensorium  (odds
ratio  (OR)  —  156,  95%  CI;  12.575—1935.197),  abnormal  reﬂexes  (OR  — 8.5,  95%  CI;
1.833—39.421)  and  edema  (OR  —  13.22,  95%  CI;  2.651—65.951).  Mortality  was  also
higher  in  those  patients  with  co-morbidities  such  as  diabetes  mellitus  (OR  —  26,  95%
CI;  2.47—273.674)  and  hypertension  (OR  —  44,  95%  CI;  6.23—315.499).  The  inde-
pendent  predictors  of  mortality  were  altered  sensorium  and  hypertension.  Dengue
fever  patients  with  these  clinical  features  and  those  who  are  elderly  should  be  more
rigorously  monitored  and  promptly  referred  from  lower  settings  when  required  to
reduce  mortality.
©  2013  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.
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mIntroductionDengue  is  one  of  the  most  serious  and  rapidly
emerging tropical  mosquito-borne  diseases.  The
global disease  burden  is  465,000  Disability  adjusted
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http://dx.doi.org/10.1016/j.jiph.2013.09.006ife  years  DALYs,  which  is only  paralleled  by  that  of
alaria among  mosquito-borne  diseases  [1]. World-
ide, approximately  2.5—3  billion  people  (40%  of
he global  population)  live  in  constant  risk  of
ontracting  this  infection.  It  is  estimated  that
0 million  cases  and  24,000  deaths  occur  annually  in
00 endemic  countries  worldwide.  Nearly  500,000
ases are  hospitalized  annually,  of  which  90%  are
 Sciences. Published by Elsevier Ltd. All rights reserved.
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iisk  factors  of  mortality  among  dengue  patients  ad
hildren.  The  south-east  Asia  region  contributes
2% of  the  cases  annually.  India  is  one  of  the  seven
dentiﬁed  countries  in  this  region  that  regularly
eports dengue  fever/dengue  hemorrhagic  fever
DF/DHF)  outbreaks.  India  appears  to  be  transfor-
ing  into  a  major  hyperendemic  niche  for  dengue
nfection. Increasingly,  previously  unaffected  areas
re being  struck  by  the  dengue  epidemic.  The  ﬁrst
onﬁrmed  report  of  dengue  infection  in  India  dates
ack to  the  1940s.  Thereafter,  several  states  began
o report  the  disease,  which  mostly  struck  in  epi-
emic  proportion,  often  inﬂicting  heavy  morbidity
nd mortality,  both  in  urban  and  rural  environments
2,3].
In Kerala,  cases  of  dengue,  including  some
eaths, were  reported  for  the  ﬁrst  time  in  1997;
evertheless, DEN-1,  DEN-2  and  DEN-4  viruses  had
een previously  detected  in  human  sera.  Dengue
ntibodies had  been  detected  in  human  sera  from
ozhikode,  Kannur,  Palakkad,  Thrissur,  Kottayam
nd Thiruvananthapuram  districts  as  early  as  1979
4].  In recent  years,  DEN-2  and  DEN-3  have  been
solated  from  vector  mosquitoes  and  human  blood
era, respectively  [5].  In  2003,  Kerala  reported  the
ighest number  of  deaths  due  to  dengue  among
ndian states,  and  over  the  years,  the  reported
ases of  dengue  in  this  region  have  been  increas-
ng [6].  The  proportion  of  deaths  contributed  by
erala  has  also  increased  from  8%  in  2006  to  15%
n 2010.  Kerala  is  now  hyper-endemic  for  dengue,
ith the  presence  of  all  four  serotypes,  high  rates
f co-infection  and  local  genomic  evolution  of  viral
trains [7].  The  district  of  Thiruvananthapuram  has
eported the  greatest  number  of  cases  in  the  state;
0—50% of  the  cases  reported  in  Thiruvananthapu-
am are  from  the  urban  areas  of  the  district  [6].
Death due  to  dengue  is  an  avoidable  cause  of
ortality [8].  The  primary  prevention  of  dengue
hrough vector  control  activities  has  had  limited
uccess worldwide  [9].  Currently,  there  is  neither
 vaccine  to  prevent  the  disease  nor  an  anti-
iral treatment.  However,  secondary  prevention  to
educe mortality  through  improved  clinical  case
anagement  has  substantially  lowered  the  mor-
ality rate  for  severe  dengue  over  the  past  two
ecades from  10—20%  to  <1%  [10,11].  The  ﬁrst
bjective of  the  WHO  global  strategy  2012—2020
s to  reduce  the  mortality  due  to  dengue  by  50%
rom 2010  levels  [12].  The  number  of  deaths  is
etermined  not  only  by  the  factors  that  facili-
ate transmission  but  also  by  those  that  inﬂuence
he severity  of  the  disease  and  the  ease  of
ealth care  access  [13]. Dengue  mortality  can
e reduced  by  the  implementation  of  early  case
etection  and  appropriate  management  of  severe
ases.  Research  to  provide  better  diagnostics  and
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iomarkers  that  can  predict  disease  severity  is
rgently needed  [12]. Organ  involvement,  shock,
acteremia,  co-morbidities,  hemorrhage  and  cer-
ain biochemical  parameters  have  been  identiﬁed
s useful  predictors  of  mortality  in  studies  con-
ucted in  dengue-endemic  countries,  but  there  may
e regional  differences.  The  objective  of  this  study
as to  identify  the  risk  factors  of  mortality  in
engue patients  admitted  to  the  Medical  College
ospital, Thiruvananthapuram  during  the  period
005—2008.
aterials and methods
tudy design
 case  control  study  was  conducted  using  the  hos-
ital records  of dengue  patients  admitted  to  the
edical  College  of  Thiruvananthapuram  during  the
eriod 2005—2008.
etting
edical  College  Hospital,  located  in  Thiruvanantha-
uram, Kerala,  India,  is  a premier  institution  for
he provision  of  comprehensive  tertiary  health  care
rrespective  of  economic  or  social  status  and  dis-
bilities.  It  is the  largest  multi-specialty  hospital  in
outh Kerala  and  serves  the  major  portion  of  the
hiruvananthapuram  and  Kollam  districts  and  the
djacent districts  of  Tamil  Nadu.
tudy population
 case  was  deﬁned  as  a  patient  who  was  admit-
ed with  a diagnosis  of  probable  dengue  conﬁrmed
y either  reverse  transcriptase  polymerase  chain
eaction  (RT-PCR)  or  IgM  antibody  and  who  died
uring the  hospital  stay.  The  controls  were  dengue-
onﬁrmed  patients  who  recovered  from  the  illness
uring  their  stay  in  the  hospital  and  were  subse-
uently discharged.
ample size and sampling technique
here  were  only  10  conﬁrmed  dengue  deaths  during
005—2008  that  met  the  eligibility  criteria;  these
ere selected  as  the  cases.  The  patients  who  met
he criteria  for  controls  were  enlisted,  and  then  40
ndividuals  were  randomly  selected  from  this  list.ata collection
 semi-structured  questionnaire  was  used  to  collect
he study  variables.  The  study  variables  included
A.  Karunakaran  et  al.
Table  1  Age  and  sex  of  the  study  subjects.
Age  Sex  Total
Male  Female
Age  <  40  years 8  (27.6%)  7  (33.3%)  15  (30.0%)
Age  >  40  years 21  (72.4%) 14  (66.7%) 35  (70.0%)
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socio-demographic  characteristics,  such  as  age
and sex,  and  clinical  details,  including  the  pres-
ence of  fever  and  associated  symptoms,  such  as
headache,  arthralgia,  myalgia,  retro-orbital  pain,
cough, anorexia,  constipation,  loose  stools,  sore
throat, rash,  vomiting,  restlessness,  abdominal
pain and  decreased  urine  output.  Important  clin-
ical signs  such  as  altered  sensorium,  abnormal
reﬂexes, ascitis,  bleeding  manifestations,  pallor,
icterus, edema,  hypotension  and  circulatory  failure
were also  collected.  The  presence  of  co-morbidities
such as  diabetes  mellitus,  hypertension,  coronary
artery disease,  tuberculosis,  liver  problems  and
renal problems  were  also  taken  as  variables.  The
history  of  previous  dengue  infection  and  habits  such
as smoking  and  alcoholism  were  assessed.  Biochem-
ical parameters  were  also  considered,  including
hemoglobin, total  cell  count,  ESR,  platelet  count,
electrolyte  imbalance,  liver  function  and  renal
function. Thrombocytopenia  was  deﬁned  as  a
platelet  count  less  than  100,000  at  any  point  during
the course  of  illness.  The  adequacy  of  vital  sign  and
temperature  monitoring  was  also  assessed.  We  also
searched for  the  presence  of  complications  such  as
shock and  any  delay  in  seeking  treatment.
Study period
The  records  of  dengue  cases  and  deaths  during  the
period 2005—2008  were  studied.
Statistical analysis
Data  entry  and  analysis  were  completed  in  SPSS
version 11.0.  Chi-square  tests  and  Fisher’s  exact
tests for  qualitative  variables  were  used  for  the
bivariate  analysis.  The  quantitative  variables  were
categorized  using  the  appropriate  cut-off  points
and medians.  Logistic  regression,  employing  the
maximum  likelihood  method,  was  used  for  the
multivariate  analysis  in  SPSS.  To  overcome  the
limitation  of  a  small  sample  size,  a  logistic  regres-
sion was  also  performed  in  ‘R’  using  the  penalized
likelihood method/Firth  method  for  ﬁtting  the
ﬁnal model.  Collinearity  between  the  predictor
variables included  in  the  model  was  ruled  out
by performing  collinearity  diagnostics  in  SPSS,
analysing  the  variance  inﬂation  factor,  tolerance
and standard  error  of  beta.
Ethical considerationsApproval  for  the  study  was  obtained  from  the  hos-
pital superintendent,  the  ofﬁcer  in  charge  of  the
record library  and  the  heads  of  the  departments
of medicine  and  community  medicine.  Clearance
s
a
pTotal 29  (100%) 21  (100%) 50  (100%)
rom  the  institutional  ethics  committee  was  also
btained.
esults
here  were  5 male  and  5  female  deaths.  The  age
nd sex  composition  of  the  study  subjects  is  dis-
layed in  Table  1.  Age  >40  years  was  found  to  be
 risk  factor  for  mortality  (p  = 0.002).  Seventy  per-
ent of  the  cases  were  above  40  years  of  age,  as
ompared  to  20%  of  the  controls.  Those  above  the
ge of  40  years  were  9.3  times  (95%  CI;  1.9—44.4)
ore likely  to  die  if  affected  by  dengue  (Table  3).
he mortality  rate  was  higher  in  females  (23.8%)
han in  males  (17.2%).
The  most  common  symptoms  among  all  patients,
n addition  to  fever  were  myalgia,  hemorrhagic
anifestations  and  vomiting,  which  were  observed
n 58%,  36%  and  32%  of the  patients,  respectively.
he most  common  symptom  in  the  survivors  was
yalgia,  whereas  hemorrhagic  manifestations  were
he most  common  symptoms  among  those  who  died
f dengue.  Among  the  symptoms  assessed,  chills,
onstipation,  abdominal  pain,  bleeding,  decreased
rine  output  and  restlessness  were  found  in  a
igher percentage  of  the  cases  than  in  the  con-
rols (Table  2). However,  these  differences  were  not
tatistically  signiﬁcant.
Among  the  signs  assessed,  altered  sensorium,
bnormal reﬂexes  and  edema  were  signiﬁcantly
ssociated with  mortality.  Pallor  was  not  associated
ith  mortality,  but  lower  hemoglobin  values  were
p =  0.045).  Those  with  co-morbidities  such  as  dia-
etes mellitus  and  hypertension  had  a higher  risk  of
ortality  than  those  who  did  not  (Table  3).  Coro-
ary artery  disease  (2%),  a  history  of  tuberculosis
3%), liver  disease  (14%)  and  renal  problems  (2%)
ere observed  in  the  study  subjects  but  were  not
ssociated  with  mortality.  A  higher  percentage  of
he controls  were  smokers  (15%  vs.  10%)  and  alco-
olics (10%  vs.  0%)  compared  with  the  cases.  No
igniﬁcant  relation  was  found  between  mortality
nd these  behaviors.
Leucopenia  was  observed  in  33  (66%)  dengue
atients, and  thrombocytopenia  was  present  in
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Table  2  Comparison  of  Symptoms  among  cases  and  controls.
Symptoms  Case  N  =  10  frequency  (%)  Control  N  =  10  frequency  (%)  Total
Chills  3  (30.0)  9  (22.5)  12  (24.0)
Arthralgia  1  (10.0)  8  (20.0)  9  (18.0)
Myalgia  3  (30.0)  26  (65.0)  29  (58.0)
Retro-orbital  pain  0  4  (10.0)  4  (8.0)
Cough  2  (20.0)  10  (25.0)  12  (24.0)
Anorexia  1  (10.0) 4 (10.0) 5  (10.0)
Constipation  1  (10.0) 2 (5.0) 3  (6.0)
Loose  stools 1  (10.0) 4 (10.0) 5  (10.0)
Abdominal  pain  2  (20.0)  7  (17.5)  9  (18.0)
Sore  throat  0  2  (5.0)  2  (4.0)
Rash  1  (10.0)  13  (32.5)  14  (28.0)
Vomiting  2  (20.0)  14  (35.0)  16  (32.0)
Bleeding  4  (40.0)  14  (35.0)  18  (36.0)
Decreased  urine  output  3  (30.0)  4  (10.0)  7  (14.0)
Headache  0  10  (25.0)  10  (20.0)
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lRestlessness  1  (10.0)  
1  (82%)  dengue  patients.  A  higher  proportion  of
atients  who  died  had  thrombocytopenia  compared
o the  survivors.  Platelet  count  returned  to  normal
t the  time  of  discharge  in  65%  of  the  survivors,
hile none  of  the  people  who  died  had  a  return
f platelet  count  to  normal.  Half  of  the  patients
ad electrolyte  imbalance.  Abnormal  liver  func-
ion test  values  were  found  in  a  higher  proportion
f patients  who  died  compared  with  survivors,
lthough the  difference  between  the  two  groups
as not  statistically  signiﬁcant  (Table  3).  Vital  signs
ere adequately  monitored  in  92%  of  the  admit-
ed patients,  whereas  temperature  monitoring  was
atisfactory  in  only  58%  of  them.  There  were  no
y
a
(
Table  3  Features  associated  with  dengue  mortality.
Case  N  =  10
frequency  (%)
Con
freq
Age  >  40  years  7  (70)  8  (
Abnormal  reﬂex  6  (60)  6  (
Altered  sensorium  8  (80)  1  (
Ascites  0  (0)  4  (
Hypotension  6  (60)  15  (
Pallor  2  (20)  2  (
Edema  7  (70)  6  (
Diabetes  mellitus  4  (40)  1(
Hypertension  7  (70)  2  (
Leucopenia  6  (60)  27  (
Elevated  ESR  3  (30)  17  (
Thrombocytopenia  10  (100)  31  (
Platelet  returned  to  normal  0  (0)  26  (
Electrolyte  imbalance 4  (40)  21  (
Abnormal  LFT  4  (40)  9  (
Anemia  7  (70)  14  (0  1  (2.0)
ifferences  in  monitoring  between  the  cases  and
he controls.
In the  logistic  regression  using  the  max-
mum likelihood  method,  the  independent
redictors  of  mortality  were  altered  senso-
ium (p  =  0.002)  and  hypertension  (p  =  0.03).  The
djusted  odds  ratios  for  altered  sensorium  was
7.3 (95%  CI;  5.3—1778.0),  and  that  for  hyper-
ension was  24.1  (95%  CI;  1.4—412.9).  To  reduce
he bias  of  small  sample  size,  the  penalized
ikelihood method  was  performed  in  R,  which
ielded the  same  predictors  of  mortality,  namely,
ltered  sensorium  (p  =  0.0003)  and  hypertension
p =  0.02).
trol  N  =  40
uency  (%)
p-Value  Odds  ratio
(95%  CI)
20)  0.002  9.3  (1.9—44.4)
15)  0.007  8.5  (1.8—39.4)
2.5)  0.000  156  (12.6—1935.2)
10)  0.3
37.5)  0.2  2.5  (0.6—10.3)
5)  0.1  4.8  (0.6—38.9)
15)  0.001  13.2  (2.6—65.9)
2.5)  0.004  26  (2.5—273.7)
5)  0.000  44.3  (6.2—315.5)
67.5)  0.7  0.7  (0.2—3.0)
42.5)  0.5  0.6  (0.1—2.6)
77.5)  0.09  1.7  (1.2—2.4)
65.0)  0.000
52.5)  0.5  0.6  (0.1—2.5)
22.5)  0.3  2.3  (0.5—9.9)
35.0)  0.045  4.3  (1.0—19.4)
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Discussion
An  important  determinant  of  mortality  identiﬁed
in our  study  was  age  greater  than  40  years.  The
risk of  mortality  due  to  dengue  is  higher  in  the
elderly [14].  A  study  in  Brazil  found  that  dengue
patients who  were  50  years  of  age  and  above  had
a 2.3-fold  higher  chance  of  mortality  than  younger
patients [1].  In  older  patients,  constitutional  symp-
toms are  less  likely,  while  multiorgan  involvement
and bacteremia  are  more  likely,  possibly  because
longer  periods  of  hospitalization  are  more  common
in this  age  group  [14,15].  Acute  renal  failure  has  a
poor prognosis  in  the  elderly  with  dengue  infection
[16].
In two  studies,  females  had  higher  rates  of
mortality due  to  dengue:  in  the  ﬁrst  study,  girls
had a  higher  risk  of  mortality  (OR  —  1.57,  95%
CI —  1.1—2.2)  [17],  and  in  the  second  study,
adult females  constituted  90%  of  the  deaths  [18].
The greater  mortality  in  females  may  be  due  to
their more  robust  immune  response,  making  them
more prone  to  developing  a  greater  inﬂammatory
response or  higher  susceptibility  to  capillary  per-
meability  [18,19].
The  presence  of  altered  sensorium  and  abnor-
mal reﬂexes  is  indicative  of  CNS  involvement.
As evidenced  in  this  study  and  suggested  in
several other  studies,  brain  involvement  is  asso-
ciated  with  a  higher  incidence  of  mortality  in
dengue patients.  Encephalopathy  may  be  due  to
acute liver  failure  from  hepatitis  [20]. Encephali-
tis may  also  be  due  to  the  neurotropic  effect
of the  virus  [21]  or  to  secondary  bacterial
infections  [22].  Coma  on  presentation  [23]  and
impaired  consciousness  are  associated  with  high
mortality  and  multi-organ  involvement  [21,24]; in
one study,  impaired  consciousness  was  found  in
57.1% of  dengue  deaths  [25]. The  occurrence  of
seizures  is  another  neurological  sign  associated  with
higher mortality  [23,26]; in  one  study,  seizures
were documented  in  33%  of  the  dengue  deaths
[26].
Hemorrhagic  manifestations  were  common
among those  patients  who  died  from  dengue  in
our setting.  Other  studies  have  also  showed  that
hemorrhagic  complications,  such  as  epistaxis,
gingival bleeding,  gastrointestinal  bleeding,  hema-
turia and  hypermenorrhea,  although  rare,  are  an
important  cause  of  death  in  dengue  [27]. In  our
study, abdominal  pain  was  more  frequent  in  the
cases than  in  the  survivors;  this  symptom  has  been
identiﬁed  as  an  early  warning  symptom,  along  with
persistent  vomiting,  and  is one  of  the  warning
signs of  dengue  according  to  the  WHO  2009  case
deﬁnition  [28,29].
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Another  important  determinant  of  mortality
dentiﬁed in  several  studies  is  the  presence  of  co-
orbidities.  Dengue  patients  with  diabetes  mellitus
16,30],  hypertension,  chronic  anemia,  conges-
ive heart  failure,  other  cardiovascular  diseases,
hronic obstructive  pulmonary  disease,  asthma,
enal disease  and  multiple  co-morbidities  were
ound to  have  a higher  incidence  of  mortality
14,25,26,30—34].  Our  study  adds  to  this  evidence.
he presence  of  acquired  co-morbidities  such  as
besity  [26], smoking  and  alcoholism  was  also  asso-
iated with  higher  mortality  [34,35]. A  relation
etween dengue  death  and  smoking  was  not  found
n our  study.
Platelet  counts  may  be  predictors  of  mortality.
hrombocytopenia  was  present  in  all  of  the  patients
ho died  of  dengue.  The  risk  of  death  was  6  times
reater in  those  with  a platelet  count  <50,000/l
n the  pediatric  population  [36]. Prolongation  of
rothrombin  time  has  been  associated  with  higher
atality [36].
Performing  concurrent  assays  for  dengue  virus
on-structural protein  1  (NS1),  anti-dengue  IgM  and
nti-dengue  IgG  along  with  platelet  enumeration  in
he ‘Dengue  Package’  is  immensely  beneﬁcial  for
atients, clinicians  and  public  health  ofﬁcials.  The
Dengue Package’  produces  an  earlier  differential
iagnosis in  suspected  cases  and  early  detection  of
hrombocytopenia,  enabling  appropriate  interven-
ion and  prevention  of  death  [37].
Higher  blood  urea  nitrogen  (uremia),  lower
icarbonate (acidosis),  higher  APTT  and  higher
GPT, SGOT  >300  mg/dl  [22]  are  also  associ-
ted with  mortality  in  dengue.  Elevated  liver
ransaminases and  hypoalbuminemia  could  be  good
ndicators of  vascular  leakage  or  hepatic  dysfunc-
ion  in  DHF  and  could  be  used  to  identify  cases
f severe  dengue  [38].  A  hemoglobin  value  of  less
han 9 mg/dl  was  associated  with  a 4-fold  higher
isk of  mortality  and/or  severity  [39]. Because  pal-
or was  not  associated  with  mortality  in  our  study,
t may  be  inferred  that  the  subjective  nature  of
his assessment  could  contribute  to  errors;  there-
ore, it  is  advisable  to  check  the  hemoglobin  level
f all  dengue  patients.  In  our  study,  abnormal  LFT
as higher  among  the  patients  who  died  of  dengue.
owever,  the  failure  to  obtain  a  statistical  signiﬁ-
ance could  be  attributed  to  the  small  sample  size,
hich  is  a  major  limitation  of  the  study  and  is  the
eason for  the  wide  conﬁdence  intervals.  As  the
ase fatality  rates  of  dengue  are  low,  especially  in
ertiary care  settings  with  good  management,  werawback of  the  study  is  that  the  study  was  retro-
pective in  nature  and  used  only  information  that
as recorded  in  the  case  sheets.  Therefore,  certain
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[isk  factors  of  mortality  among  dengue  patients  ad
rucial  determinants  of  mortality,  such  as  serotype,
ould not  be  studied.
onclusions
atients  with  dengue  fever  who  have  altered  sen-
orium,  abnormal  reﬂex,  edema,  diabetes  mellitus,
ypertension  and  persistently  low  platelet  count
ave a  higher  risk  of  mortality.  At  primary  and  sec-
ndary levels  of  health  care  delivery,  patients  with
hese symptoms  must  be  promptly  referred.  At  ter-
iary levels,  dengue  patients  with  these  clinical
eatures should  be  given  extra  care  and  monitored
ore rigorously  so  that  mortality  can  be  decreased.
pecial care  and  attention  should  be  given  to  the
lderly  at  all  levels  of  healthcare  to  reduce  mortal-
ty.
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